Zobrazeno 1 - 10
of 645
pro vyhledávání: '"Tramontano AC"'
Autor:
Iheanacho F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Tramontano AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Manz CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cancer [Cancer] 2024 Nov 12. Date of Electronic Publication: 2024 Nov 12.
Autor:
Wong JS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Uno H; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Tramontano AC; Dana-Farber Cancer Institute, Boston, Massachusetts., Fisher L; Dana-Farber Cancer Institute, Boston, Massachusetts., Pellegrini CV; Dana-Farber Cancer Institute, Boston, Massachusetts., Abel GA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Burstein HJ; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Chun YS; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., King TA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Schrag D; Memorial Sloan Kettering Cancer Center, New York, New York., Winer E; Yale Cancer Center, New Haven, Connecticut., Bellon JR; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Cheney MD; Maine Medical Center, Portland, Maine., Hardenbergh P; Vail Health, Vail, Colorado., Ho A; Duke University Medical Center, Durham, North Carolina., Horst KC; Stanford University School of Medicine, Stanford, California., Kim JN; Fred Hutchinson Cancer Center/UW Medicine, Seattle, Washington., Leonard KL; Warren Alpert Medical School of Brown University, Providence, Rhode Island.; Rhode Island Hospital, Providence., Moran MS; Yale Cancer Center, New Haven, Connecticut., Park CC; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Recht A; Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Soto DE; Massachusetts General Hospital, Boston., Shiloh RY; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Stinson SF; Johns Hopkins School of Medicine, Baltimore, Maryland., Snyder KM; Northern Light Health, Brewer, Maine., Taghian AG; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston., Warren LE; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Wright JL; Johns Hopkins School of Medicine, Baltimore, Maryland., Punglia RS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Oct 01; Vol. 10 (10), pp. 1370-1378.
Autor:
Cotner CE; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Tramontano AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Post A; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Finn B; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Awan S; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Gwynne N; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA., Mwesigwa S; Mathematica, Cambridge, MA., Lindvall C; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA., Tulsky JA; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA., Jacobson JO; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Jackman DM; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wright AA; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Manz CR; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Sep 30, pp. OP2400311. Date of Electronic Publication: 2024 Sep 30.
Autor:
Ozanne EM; Department of Population Health Sciences, School of Medicine, University of Utah, Population Health Sciences, 295 Chipeta Way Rm 1N512, Salt Lake City, UT, 84108, USA. elissa.ozanne@hsc.utah.edu., Maves K; University of Utah, Salt Lake City, UT, USA., Tramontano AC; Division of Population Sciences, Dana-Farber/Partners Cancer Care Institute, Boston, MA, USA., Lynch T; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Thompson A; Baylor College of Medicine, Houston, TX, USA., Partridge A; Dana-Farber Cancer Institute, Boston, MA, USA., Frank E; Alliance Foundation Trials, LLC, Boston, MA, USA., Collyar D; Alliance Foundation Trials, LLC, Boston, MA, USA., Basila D; Alliance Foundation Trials, LLC, Boston, MA, USA., Pinto D; Alliance Foundation Trials, LLC, Boston, MA, USA., Hyslop T; Thomas Jefferson University, Philadelphia, PA, USA., Ryser MD; Department of Population Health Sciences, Duke University Medical Center, Durham, NC, USA., Rosenberg S; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA., Hwang ES; Duke University Medical Center, Durham, NC, USA., Punglia RS; Department of Radiation Oncology, Dana-Farber/Partners Cancer Care, Boston, MA, USA.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 Sep 17; Vol. 26 (1), pp. 134. Date of Electronic Publication: 2024 Sep 17.
Autor:
Lee DJ; Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., El-Khoury H; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Tramontano AC; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA., Alberge JB; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Perry J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Davis MI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Horowitz E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Redd R; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA., Sakrikar D; The Binding Site Inc, Rochester, MN., Barnidge D; The Binding Site Inc, Rochester, MN., Perkins MC; The Binding Site Group Ltd, Birmingham, United Kingdom., Harding S; The Binding Site Group Ltd, Birmingham, United Kingdom., Mucci L; Harvard T.H. Chan School of Public Health, Boston, MA., Rebbeck TR; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.; Harvard T.H. Chan School of Public Health, Boston, MA., Ghobrial IM; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA., Marinac CR; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2024 Apr 09; Vol. 8 (7), pp. 1737-1746.
Autor:
Paudel R; Dana-Farber Cancer Institute, Boston, MA., Tramontano AC; Dana-Farber Cancer Institute, Boston, MA., Cronin C; Dana-Farber Cancer Institute, Boston, MA., Wong SL; Dartmouth-Hitchcock Medical Center, Lebanon, NH., Dizon DS; Lifespan Cancer Institute and Brown University, Providence, RI., Jenkins HH; West Virginia University Cancer Center, Morgantown, WV., Bian J; Maine Medical Center, Portland, ME., Osarogiagbon RU; Baptist Memorial Healthcare Corporation, Memphis, TN., Schrag D; Memorial Sloan Kettering Cancer Center, New York, NY., Hassett MJ; Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Jan; Vol. 20 (1), pp. 77-84. Date of Electronic Publication: 2023 Nov 27.
Autor:
Kuczmarski TM; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, USA., Tramontano AC; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Mozessohn L; Department of Hematology and Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., LaCasce AS; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA., Roemer L; Department of Psychology, University of Massachusetts, Boston, MA, USA., Abel GA; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA., Odejide OO; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: Oreofe_Odejide@dfci.harvard.edu.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2023 Jul; Vol. 10 (7), pp. e530-e538. Date of Electronic Publication: 2023 Jun 01.
Autor:
Manz CR; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts., Tramontano AC; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Uno H; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Parikh RB; Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Penn Center for Cancer Care Innovation, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania., Bekelman JE; Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Penn Center for Cancer Care Innovation, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Schrag D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Sep 01; Vol. 5 (9), pp. e2234161. Date of Electronic Publication: 2022 Sep 01.
Autor:
Stavrou E; Dana Farber Cancer Institute.; Harvard Medical School., Qiu J; Harvard Medical School., Zafar A; Dana Farber Cancer Institute.; Harvard Medical School.; Brigham and Women's Hospital., Tramontano AC; Dana Farber Cancer Institute., Isakoff S; Harvard Medical School.; Massachusetts General Cancer Center., Winer E; Dana Farber Cancer Institute.; Harvard Medical School., Schrag D; Memorial Sloan Kettering Cancer Center., Manz C; Dana Farber Cancer Institute.; Harvard Medical School.; Brigham and Women's Hospital.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2022 Sep; Vol. 18 (9), pp. e1447-e1453. Date of Electronic Publication: 2022 Jun 07.
Autor:
Lui G; Departments of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Departments of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Hassett MJ; Departments of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Tramontano AC; Departments of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Uno H; Departments of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Punglia RS; Department of Radiation Oncology, Brigham & Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Advances in radiation oncology [Adv Radiat Oncol] 2022 Jul 19; Vol. 7 (6), pp. 101017. Date of Electronic Publication: 2022 Jul 19 (Print Publication: 2022).